Effect of Tissue Plasminogen Activator Dose and Interval on Stroke Severity
Excerpt: The recent study by Sahlas et al1 in the Journal of Stroke and Cerebrovascular Diseases concluded that “the estimation of a patient's weight in the acute setting can lead to overcalculation of the tissue plasminogen activator dose, which is associated with poorer functional outcomes.”...
| Main Authors: | , |
|---|---|
| Published: |
Digital Commons @ East Tennessee State University
2014
|
| Subjects: | |
| Online Access: | https://dc.etsu.edu/etsu-works/7480 https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.023 |